2,620
Views
12
CrossRef citations to date
0
Altmetric
Original Articles

Synthesis and antitumor activity of tetrahydrocarbazole hybridized with dithioate derivatives

Pages 308-315 | Received 31 Mar 2014, Accepted 05 May 2014, Published online: 05 Jun 2014

Figures & data

Figure 1. Structures of biologically active dithiocarbamates and carbazoles.

Figure 1. Structures of biologically active dithiocarbamates and carbazoles.

Scheme 1. Synthesis of tetrahydrocarbazoles hybridized with dithioate derivatives.

Scheme 1. Synthesis of tetrahydrocarbazoles hybridized with dithioate derivatives.

Figure 2. The 1H-NMR and 13C-NMR chemical shifts for compound 6b. The data are expressed as δ in ppm unit, br s: broad singlet; s: singlet; t: triplet; m: multiplet.

Figure 2. The 1H-NMR and 13C-NMR chemical shifts for compound 6b. The data are expressed as δ in ppm unit, br s: broad singlet; s: singlet; t: triplet; m: multiplet.

Figure 3. Effect of conjugation between C=S and nitrogen atom.

Figure 3. Effect of conjugation between C=S and nitrogen atom.

Figure 4. IC50 in nM/mL of compounds 4–7 and doxorubicin against MCF7 and HCT116 cell lines.

Figure 4. IC50 in nM/mL of compounds 4–7 and doxorubicin against MCF7 and HCT116 cell lines.

Table 1. Results of in vitro cytotoxic activity of the synthesized compounds on human breast adenocarcinoma cell line (MCF7) and human colon tumor cell line (HCT116).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.